Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 380 results for "cadila health"

Pharma firms to be hit as drug regulator caps prices

Pharma majors to be hit as drug regulator caps prices

In a move that might impact major drug makers such as Ranbaxy, Cipla, Cadila Health, and Lupin, the National Pharmaceutical Pricing Authority (NPPA) has capped the prices of 19 medicines and their 43 different drug packs, including anti-infectives, ... Business Standard India, 1 day ago

3 images for "cadila health"

India TV, 2 hours ago
Business Today India, 5 hours ago
Money Control, 1 month ago
India TV

Zydus gets tentative nod from USFDA to market diabetic tablets

PTI [ Updated 16 Sep 2014, 16:07:55 ] New Delhi: Drug firm Zydus Cadila has received a tentative nod from the health regulator USFDA to market Glipizide tablets, used for treatment of diabetes, in America. "Zydus Cadila has received tentative ...
 India TV4 days ago Cadila Health up 3%, diabetic drug gets tentative USFDA nod  Money Control4 days ago Zydus gets USFDA tentative nod for diabetic tablets  Press Trust of India4 days ago Zydus gets USFDA tentative nod to market anti-diabetic tablets  The Financial Chronicle4 days ago
Business Standard India

Gilead Licenses Hepatitis Therapy in India Amid Price Criticism

Gilead Sciences Inc. The agreements allow Cadila Healthcare Ltd. (CDH), Cipla Ltd., Hetero Labs Ltd., Mylan Laboratories Ltd. The drug's pricing has drawn criticism from pharmacy benefit managers, as well as questions from U.S. Senators Charles ...
 BusinessWeek5 days ago Drug makers sign pact with Gilead for cheaper Hepatitis-C drug  Smart Investor4 days ago Gilead inks licensing pacts for Hep C drug with Ranbaxy, Cipla, Mylan, four Indian firms  Business Standard India3 days ago Gilead (GILD) Slips on Generic Sovaldi Licensing Deals  Yahoo! Finance3 days ago
Business Standard

Zydus Cadila gets USFDA nod for kidney stones tablets

Drug firm Zydus Cadila has received the final approval from the US health regulator to market Potassium Citrate ER tablets used in prevention of kidney stones. Zydus Cadila has received the final approval from the United States Food and Drug Administration ...
 Business Standard1 month ago Zydus Cadila Gets US Regulatory Nod for Kidney Stone Tablets  NDTV Profit1 month ago Zydus Cadila gets US FDA nod to market kidney stone tablets  Livemint.com1 month ago Zydus Cadila gets United States Food and Drug Administration nod for kidney stones tablets  Economic Times1 month ago
Business Standard India

Cadila Healthcare: Updates on outcome of AGM

Cadila Healthcare Ltd has submitted to BSE a copy of proceedings of the 19th Annual General Meeting of the members of the Company held on July 30, 2014.Source : BSE Read all announcements in Cadila Health To read the full report
 Moneycontrol.com1 month ago Cadila's Moraiya facility under US FDA lens  Business Standard India1 month ago USFDA raises a red flag for Cadila's ANDA application  Business Standard India1 month ago FDA raises concern over drug production process at Cadila  Moneycontrol.com1 month ago

Focus on stocks, says Dipan Mehta; picks top 5 phama bets

D On specific stocks, he is betting on pharma stocks and likes Ajanta Pharma , IPCA Labs , Cadila Health , Torrent Pharma and Alembic Pharma . From the FMCG space, he is cautious on cigarette major ITC on the back of tobacco business-related ...
 Moneycontrol.com1 month ago Pharma stocks outperform equity benchmarks, rally 2-14%  Moneycontrol.com1 month ago

Neutral on Cadila Health, target Rs 1,180: Espirito Santo

Summary We remain neutral on Cadila Healthcare (CDH) due to lopsided growth, but revise our target price to R1,180 (earlier R910) as we roll our valuations forward to July 2015. We value Cadila using our standard three-stage DCF model with five-year ...
 Financial Express1 month ago Buy SKS Micro, Bharat Forge, Cadila Health: Dharmesh Kant  Money Control1 month ago Cadila Health up 2.5%, Credit Suisse maintains outperform  Money Control2 months ago

Cadila Health at new high on USFDA nod for anti-viral drug

Zydus Cadila has received the final approval from the USFDA to market Acyclovir tablets in the strenths of 400 mg and 800 mg.
 Money Control1 month ago

Bull's Eye: India Cements, IRB Infra, Cadila Health, SKS

Vishal Malkan, advises buying India Cements for a target price of Rs 110 and Adani Enterprises for a target price of Rs 450.
 Money Control1 month ago Buy Hathway Cable, Cadila Health, Wockhardt: AK Prabharkar  Money Control1 month ago

Cadila Healthcare drops on buzz of rating downgrade from a foreign brokerage

The barometer index, the S&P BSE Sensex, slipped once again into the red from positive terrain whereas the 50-unit CNX Nifty languished in the negative terrain near the flat line in early afternoon trade. The Sensex was currently down 13.67 points ...
 Business Standard India1 month ago Sun Pharma, Ranbaxy slump  Business Standard India1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less